Gammoh Omar, Alsous Mervat, Al-Ameri Mariam, Al-Jabari Sereene, Sbitan Lana, Alsheyyab Jafar, Zeitoon Sa'ed, Hanandeh Suzan, Aljabali Alaa A A, AlRasheed Hayam Ali, Shilbayeh Sireen Abdul Rahim
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Healthcare (Basel). 2024 Dec 19;12(24):2559. doi: 10.3390/healthcare12242559.
BACKGROUND/OBJECTIVES: The prevalence of type 2 diabetes and smoking is increasing in developing countries and is associated with deteriorated health outcomes. Also, addiction to smartphone use is an alarming behavior that can be associated with clinical factors. This study aimed to determine the prevalence and clinical correlates of smartphone addiction in smokers with T2DM in Jordan, with a particular focus on the role of medications.
This cross-sectional study recruited patients from Prince Hamza Hospital, Jordan, according to pre-defined criteria. Besides demographics and clinical information, this study used the validated Arabic version of the Smartphone Addiction Scale to assess addiction to smartphones and a multivariable regression analysis to identify the correlates of smartphone addiction.
Data analyzed from 346 patients revealed that 117 (33.8%) of these participants reported addiction to smartphones. Patients who had been diagnosed with T2DM for less than five years (aOR = 3.30; 95% CI = 1.43-7.60), who were "employed" (aOR = 8.85; 95% CI = 2.20-35.64), and who were "retired" (aOR = 11.46; 95% CI = 2.72-48.23) all reported a significantly ( < 0.05) higher odds of smartphone addiction. In contrast, patients on "sulfonylurea" (aOR = 0.18; 95% CI = 0.06-0.53); "metformin" (aOR = 0.19; 95% CI = 0.06-0.66), and "gabapentin" (aOR = 0.16; 95% CI = 0.04-0.67) and those with "comorbid hypertension" (aOR = 0.15; 95% CI = 0.06-0.38) had a significantly ( < 0.05) lower odds of smartphone addiction.
These alarming results require adequate action from the health authorities to raise awareness of adopting positive behaviors that could improve the well-being of this high-risk population.
背景/目的：在发展中国家，2型糖尿病和吸烟的患病率正在上升，且与健康状况恶化相关。此外，沉迷于使用智能手机是一种令人担忧的行为，可能与临床因素有关。本研究旨在确定约旦2型糖尿病吸烟者中智能手机成瘾的患病率及其临床相关因素，特别关注药物的作用。
这项横断面研究根据预先定义的标准，从约旦哈姆扎王子医院招募患者。除了人口统计学和临床信息外，本研究使用经过验证的阿拉伯语版智能手机成瘾量表来评估对智能手机的成瘾情况，并通过多变量回归分析来确定智能手机成瘾的相关因素。
对346名患者的数据分析显示，其中117名（33.8%）参与者报告有智能手机成瘾问题。被诊断为2型糖尿病不到五年的患者（调整后比值比[aOR]=3.30；95%置信区间[CI]=1.43 - 7.60）、“在职”患者（aOR = 8.85；95% CI = 2.20 - 35.64）以及“退休”患者（aOR = 11.46；95% CI = 2.72 - 48.23）报告的智能手机成瘾几率均显著较高（<0.05）。相比之下，使用“磺脲类药物”的患者（aOR = 0.18；95% CI = 0.06 - 0.53）、使用“二甲双胍”的患者（aOR = 0.19；95% CI = 0.06 - 0.66）、使用“加巴喷丁”的患者（aOR = 0.16；95% CI = 0.04 - 0.67）以及患有“合并高血压”的患者（aOR = 0.15；95% CI = 0.06 - 0.38）的智能手机成瘾几率显著较低（<0.05）。
这些令人担忧的结果要求卫生当局采取适当行动，提高对采取积极行为以改善这一高危人群健康状况的认识。
